Covalent drugs based on small molecules and peptides for disease theranostics

Ying-Jin Zhang, Jian-Xiao Liang, Yin-Sheng Xu, Yi-Xuan Liu, Yingying Cui, Zeng-Ying Qiao and Hao Wang

Biomater. Sci., 2024, 12, 564
DOI: 10.1039/D3BM01138K

Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2

Anjani, Sumit Kumar, Brijesh Rathi and Poonam

RSC Adv., 2023, 13, 3677
DOI: 10.1039/D2RA06834F

Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 Mpro by large-scale molecular dynamic simulations combined with accurate binding free energy calculations

Song Luo, Kaifang Huang, Xiaoyu Zhao, Yalong Cong, John Z. H. Zhang and Lili Duan

Nanoscale, 2021, 13, 8313
DOI: 10.1039/D0NR07833F

Targeting proteases involved in the viral replication of SARS-CoV-2 by sesquiterpene lactones from chicory (Cichorium intybus L.)

María Ángeles Ávila-Gálvez, Carlos Rafael-Pita, Naiara Fernández, João Baixinho, José D. Anastácio, Katarina Cankar, Dirk Bosch and Cláudia Nunes dos Santos

Food Funct., 2022, 13, 8977
DOI: 10.1039/D2FO00933A

Characterizing the ligand-binding affinity toward SARS-CoV-2 Mproviaphysics- and knowledge-based approaches

Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Van V. Vu, Minh Quan Pham and Binh Khanh Mai

Phys. Chem. Chem. Phys., 2022, 24, 29266
DOI: 10.1039/D2CP04476E

Insights from computational analysis: how does the SARS-CoV-2 Delta (B.1.617.2) variant hijack ACE2 more effectively?

Danyang Xiong, Xiaoyu Zhao, Song Luo and Lili Duan

Phys. Chem. Chem. Phys., 2022, 24, 8683
DOI: 10.1039/D2CP00843B

Multiplexed droplet loop-mediated isothermal amplification with scorpion-shaped probes and fluorescence microscopic counting for digital quantification of virus RNAs

Ya-Ling Tan, A-Qian Huang, Li-Juan Tang and Jian-Hui Jiang

Chem. Sci., 2021, 12, 8445
DOI: 10.1039/D1SC00616A

Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs

Xiaoyu Zhao, Song Luo, Kaifang Huang, Danyang Xiong, John Z. H. Zhang and Lili Duan

Nanoscale, 2021, 13, 19218
DOI: 10.1039/D1NR06313H

Molecular investigation of the dual inhibition mechanism for targeted P53 regulator MDM2/MDMX inhibitors

Xiaoyu Zhao, Danyang Xiong, Song Luo and Lili Duan

Phys. Chem. Chem. Phys., 2022, 24, 16799
DOI: 10.1039/D2CP01780F

Nanoscience and quantum science-led biocidal and antiviral strategies

Mina Zare, Vinoy Thomas and Seeram Ramakrishna

J. Mater. Chem. B, 2021, 9, 7328
DOI: 10.1039/D0TB02639E

Relationship Between Phylogenetic of Apium and Foeniculum Plants from Central Java, Indonesia, and Their Secondary Metabolites Potency against COVID-19 Protease

Hermin Pancasakti Kusumaningrum, Rejeki Siti Ferniah, Siti Nur Jannah, Mufida Budi Kurniawati, Anis Afifah, Yoshua Mario Sumbodo, Salma Seftia Hanif, Tia Erfianti and Yuriza Eshananda

Open Access Maced J Med Sci, 2022, 10, 1234
DOI: 10.3889/oamjms.2022.9852

Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL pro main protease (Mpro) from proteomic identification of P6—P6' active site specificity

Hugo Cesar Ramos de Jesus, Nestor Solis, Yoan Machado, Isabel Pablos, Peter A. Bell, Reinhild Kappelhoff, Peter M. Grin, Carlos A. Sorgi, Georgina S. Butler, Christopher M. Overall and Tom Gallagher

J Virol, 2024, 98
DOI: 10.1128/jvi.00049-24

Topology-Based and Conformation-Based Decoys Database: An Unbiased Online Database for Training and Benchmarking Machine-Learning Scoring Functions

Xujun Zhang, Chao Shen, Tianyue Wang, Yu Kang, Dan Li, Peichen Pan, Jike Wang, Gaoang Wang, Yafeng Deng, Lei Xu, Dongsheng Cao, Tingjun Hou and Zhe Wang

J. Med. Chem., 2023, 66, 9174
DOI: 10.1021/acs.jmedchem.3c00801

Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

Hylemariam Mihiretie Mengist, Tebelay Dilnessa and Tengchuan Jin

Front. Chem., 2021, 9
DOI: 10.3389/fchem.2021.622898

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19

Himanshu Rai, Atanu Barik, Yash Pal Singh, Akhil Suresh, Lovejit Singh, Gourav Singh, Usha Yogendra Nayak, Vikash Kumar Dubey and Gyan Modi

Mol Divers, 2021, 25, 1905
DOI: 10.1007/s11030-021-10188-5

Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2

Yao Sun, Yanqi Jiao, Chengcheng Shi and Yang Zhang

Computational and Structural Biotechnology Journal, 2022, 20, 5014
DOI: 10.1016/j.csbj.2022.09.002

Mutations in Main Protease of SARS CoV-2 Decreased Boceprevir Affinity

Ekrem Akbulut

Braz. arch. biol. technol., 2021, 64
DOI: 10.1590/1678-4324-2021200803

In silico identification of D449-0032 compound as a putative SARS-CoV-2 M pro inhibitor

Gisele Strieder Philippsen and Flavio Augusto Vicente Seixas

Journal of Biomolecular Structure and Dynamics, 2024, 42, 6440
DOI: 10.1080/07391102.2023.2234045

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

Souvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo O. Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong, Bernd Meibohm, Duane D. Miller, Colleen B. Jonsson and Kshatresh Dutta Dubey

J. Chem. Inf. Model., 2021, 61, 5469
DOI: 10.1021/acs.jcim.1c00524

Contribution of Deep-Learning Techniques Toward Fighting COVID-19: A Bibliometric Analysis of Scholarly Production During 2020

Janneth Chicaiza, Stephany D. Villota, Paola G. Vinueza-Naranjo and Ruben Rumipamba-Zambrano

IEEE Access, 2022, 10, 33281
DOI: 10.1109/ACCESS.2022.3159025

Deep Learning in COVID-19 Diagnosis, Prognosis and Treatment Selection

Suya Jin, Guiyan Liu and Qifeng Bai

Mathematics, 2023, 11, 1279
DOI: 10.3390/math11061279

Comprehensive in silico screening of flavonoids against SARS-CoV-2 main protease

Maryam Sadat Moezzi

Journal of Biomolecular Structure and Dynamics, 2023, 41, 9448
DOI: 10.1080/07391102.2022.2142297

Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease

Ogunyemi Olajide Oderinlo, Chiamaka Gift Iwegbulam, Overcomer Abumonye Ekweli, Taye T. Alawode and Oluwatoba Emmanuel Oyeneyin

Chemistry Africa, 2022, 5, 1441
DOI: 10.1007/s42250-022-00440-2

Multiphysical graph neural network (MP-GNN) for COVID-19 drug design

Xiao-Shuang Li, Xiang Liu, Le Lu, Xian-Sheng Hua, Ying Chi and Kelin Xia

Briefings in Bioinformatics, 2022, 23
DOI: 10.1093/bib/bbac231

Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges

Junjie Peng, Elizabeth C. Jury, Pierre Dönnes and Coziana Ciurtin

Front. Pharmacol., 2021, 12
DOI: 10.3389/fphar.2021.720694

Natural inhibitors for severe acute respiratory syndrome coronavirus 2 main protease from Moringa oleifera, Aloe vera, and Nyctanthes arbor-tristis: molecular docking and ab initio fragment molecular orbital calculations

Divya Shaji, Ryo Suzuki, Shohei Yamamoto, Daisuke Orihashi and Noriyuki Kurita

Struct Chem, 2022, 33, 1771
DOI: 10.1007/s11224-022-02021-y

Perspectives on SARS-CoV-2 Main Protease Inhibitors

Kaifu Gao, Rui Wang, Jiahui Chen, Jetze J. Tepe, Faqing Huang and Guo-Wei Wei

J. Med. Chem., 2021, 64, 16922
DOI: 10.1021/acs.jmedchem.1c00409

Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management

Christos Papaneophytou

IJMS, 2024, 25, 8105
DOI: 10.3390/ijms25158105

The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?

Ahmed A. Ezat, Jameel M. Abduljalil, Ahmed M. Elghareib, Ahmed Samir and Abdo A. Elfiky

Expert Opinion on Drug Discovery, 2023, 18, 551
DOI: 10.1080/17460441.2023.2199980

SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots

Pol Garcia-Segura, Ariadna Llop-Peiró, Nil Novau-Ferré, Júlia Mestres-Truyol, Bryan Saldivar-Espinoza, Gerard Pujadas and Santiago Garcia-Vallvé

Computers in Biology and Medicine, 2025, 184, 109344
DOI: 10.1016/j.compbiomed.2024.109344

Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by in-silico simulation study

Shovonlal Bhowmick, Tapan Kumar Mistri, Mohammad Rizwan Khan, Pritee Chunarkar Patil, Rosa Busquets, Abu Md Ashif Ikbal, Ankita Choudhury, Dilip Kumar Roy, Partha Palit and Achintya Saha

Journal of Biomolecular Structure and Dynamics, 2024, 42, 7107
DOI: 10.1080/07391102.2023.2238065

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro

Shani Zev, Keren Raz, Renana Schwartz, Reem Tarabeh, Prashant Kumar Gupta and Dan T. Major

J. Chem. Inf. Model., 2021, 61, 2957
DOI: 10.1021/acs.jcim.1c00263

Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy

Yanling Wu, Kun Li, Menglong Li, Xuemei Pu and Yanzhi Guo

J. Chem. Inf. Model., 2023, 63, 7011
DOI: 10.1021/acs.jcim.3c01280

RETRACTED ARTICLE: Drug discovery through Covid-19 genome sequencing with siamese graph convolutional neural network

Soumen Kumar Pati, Manan Kumar Gupta, Ayan Banerjee, Rinita Shai and Palaiahnakote Shivakumara

Multimed Tools Appl, 2024, 83, 61
DOI: 10.1007/s11042-023-15270-8

Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2

Shailima Rampogu, Gihwan Lee, Jun Sung Park, Keun Woo Lee and Myeong Ok Kim

IJMS, 2022, 23, 1771
DOI: 10.3390/ijms23031771

Paxlovid: Mechanism of Action, Synthesis, and In Silico Study

Mahrokh Marzi, Mohammad Kazem Vakil, Maryam Bahmanyar, Elham Zarenezhad and Tanveer A. Wani

BioMed Research International, 2022, 2022
DOI: 10.1155/2022/7341493

The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation

Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova and Paul Christakopoulos

Biomedicines, 2022, 10, 1787
DOI: 10.3390/biomedicines10081787

Predicting drug–target binding affinity through molecule representation block based on multi-head attention and skip connection

Li Zhang, Chun-Chun Wang and Xing Chen

Briefings in Bioinformatics, 2022, 23
DOI: 10.1093/bib/bbac468

Structural insights into the substrate‐binding site of main protease for the structure‐based COVID‐19 drug discovery

Rohoullah Firouzi, Mitra Ashouri and Mohammad Hossein Karimi‐Jafari

Proteins, 2022, 90, 1090
DOI: 10.1002/prot.26318

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2

Wenhan Guo, Yixin Xie, Alan E Lopez-Hernandez, Shengjie Sun and Lin Li

MBE, 2021, 18, 2372
DOI: 10.3934/mbe.2021120

Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75

Shengnan Yin, Shuang Mei, Zhiqin Li, Zhen Xu, Yuting Wu, Xiujuan Chen, Dongmei Liu, Miao-Miao Niu and Jindong Li

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.1037993

A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors

Padmika Madushanka Wadanambi, Nimanthi Jayathilaka and Kapila N. Seneviratne

Appl Biochem Biotechnol, 2023, 195, 573
DOI: 10.1007/s12010-022-04138-6

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen

Liying Wang, Zhongtian Yu, Shiwei Wang, Zheng Guo, Qi Sun and Luhua Lai

European Journal of Medicinal Chemistry, 2022, 244, 114803
DOI: 10.1016/j.ejmech.2022.114803

In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants

Calvin R. Wei, Zarrin Basharat and Godwin C. Lang’at

DDC, 2024, 3, 54
DOI: 10.3390/ddc3010005

Evaluating the Synergistic Effects of Multi-Epitope Nanobodies on BA.2.86 Variant Immune Escape

Jinxin Liu, Song Luo, Xiaole Xu, Enhao Zhang, Houde Liang, John Z. H. Zhang and Lili Duan

J. Phys. Chem. Lett., 2025, 16, 396
DOI: 10.1021/acs.jpclett.4c03028

Theoretical investigating mechanisms of drug-resistance generated by mutation-induced changes in influenza viruses

Song Luo, Xiaoyu Zhao, Yihui Wang and Lili Duan

Chinese Journal of Chemical Physics, 2021, 34, 785
DOI: 10.1063/1674-0068/cjcp2110193

Deep learning for drug repurposing: Methods, databases, and applications

Xiaoqin Pan, Xuan Lin, Dongsheng Cao, Xiangxiang Zeng, Philip S. Yu, Lifang He, Ruth Nussinov and Feixiong Cheng

WIREs Comput Mol Sci, 2022, 12
DOI: 10.1002/wcms.1597

Phytochemical drug discovery for COVID-19 using high-resolution computational docking and machine learning assisted binder prediction

Zirui Wang, Theodore Belecciu, Joelle Eaves, Mark Reimers, Michael H. Bachmann and Daniel Woldring

Journal of Biomolecular Structure and Dynamics, 2023, 41, 6643
DOI: 10.1080/07391102.2022.2112976

Deep learning methods for molecular representation and property prediction

Zhen Li, Mingjian Jiang, Shuang Wang and Shugang Zhang

Drug Discovery Today, 2022, 27, 103373
DOI: 10.1016/j.drudis.2022.103373

Artificial intelligence based methods for hot spot prediction

Damla Ovek, Zeynep Abali, Melisa Ece Zeylan, Ozlem Keskin, Attila Gursoy and Nurcan Tuncbag

Current Opinion in Structural Biology, 2022, 72, 209
DOI: 10.1016/j.sbi.2021.11.003

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2

Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei and Guo-Wei Wei

Chem. Rev., 2022, 122, 11287
DOI: 10.1021/acs.chemrev.1c00965

Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations

Bilal Ahmad, Maria Batool, Qurat ul Ain, Moon Suk Kim and Sangdun Choi

IJMS, 2021, 22, 9124
DOI: 10.3390/ijms22179124

GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores

Li Zhang, Chun-Chun Wang, Yong Zhang and Xing Chen

Computers in Biology and Medicine, 2023, 166, 107512
DOI: 10.1016/j.compbiomed.2023.107512

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies

N. Anis Ahamed and Ibrahim A. Arif

Saudi Journal of Biological Sciences, 2023, 30, 103845
DOI: 10.1016/j.sjbs.2023.103845

In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19

Sabeena Mustafa, Lamya A. Alomair and Mohamed Hussein

Processes, 2022, 10, 1397
DOI: 10.3390/pr10071397

AI's role in pharmaceuticals: Assisting drug design from protein interactions to drug development

Solene Bechelli and Jerome Delhommelle

Artificial Intelligence Chemistry, 2024, 2, 100038
DOI: 10.1016/j.aichem.2023.100038

Vitamin K as a Simple but Efficient Add-on to the Current Treatment Regime of COVID-19: A Narrative Review

Souparnika Sreelatha, Nayana Devang and Aradhana Marathe

CNF, 2022, 18, 610
DOI: 10.2174/1573401318666220405134759

Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrins

Vipul Kumar, Hazna Noor Meidinna, Sunil C. Kaul, Dharmender Gupta, Yoshiyuki Ishida, Keiji Terao, Sudhanshu Vrati, Durai Sundar and Renu Wadhwa

Journal of Biomolecular Structure and Dynamics, 2025, 43, 2890
DOI: 10.1080/07391102.2023.2294385

Imidazole-Based Alkaloids from Marine Sponges ( Leucetta and Clathrina ) as Potential Inhibitors Targeting SARS-CoV-2 Main Protease: An In Silico Approach

Peter Solo and M. Arockia doss

Polycyclic Aromatic Compounds, 2024, 44, 897
DOI: 10.1080/10406638.2023.2182796

A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?

Guillem Macip, Pol Garcia-Segura, Júlia Mestres-Truyol, Bryan Saldivar-Espinoza, Gerard Pujadas and Santiago Garcia-Vallvé

IJMS, 2021, 23, 259
DOI: 10.3390/ijms23010259

Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor

Leena H. Bajrai, Arwa A. Faizo, Areej A. Alkhaldy, Vivek Dhar Dwivedi, Esam I. Azhar and Chandrabose Selvaraj

PLoS ONE, 2022, 17, e0277328
DOI: 10.1371/journal.pone.0277328

Drug Resistance Predictions Based on a Directed Flag Transformer

Dong Chen, Gengzhuo Liu, Hongyan Du, Benjamin Jones, Junjie Wee, Rui Wang, Jiahui Chen, Jana Shen and Guo‐Wei Wei

Advanced Science, 2025, 12
DOI: 10.1002/advs.202502756

Protein degradation: a novel computational approach to design protein degrader probes for main protease of SARS-CoV-2

Muhammed Shaheer, Ravi Singh and M. Elizabeth Sobhia

Journal of Biomolecular Structure and Dynamics, 2022, 40, 10905
DOI: 10.1080/07391102.2021.1953601